0001181431-12-000831.txt : 20120104 0001181431-12-000831.hdr.sgml : 20120104 20120104170559 ACCESSION NUMBER: 0001181431-12-000831 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120102 FILED AS OF DATE: 20120104 DATE AS OF CHANGE: 20120104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMahon Gerald PhD CENTRAL INDEX KEY: 0001290747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 12507199 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd329796.xml X0304 4 2012-01-02 0 0000908259 OXIGENE INC OXGN 0001290747 McMahon Gerald PhD C/O: OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 0.99 2012-01-02 4 A 0 28300 0 A 2012-01-02 2018-01-02 Common Stock 28300 28300 D Dr. McMahon elected to receive options to purchase shares of OXiGENE, Inc. common stock (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy as partial payment for Board of Directors services to be provided during the first six months of 2012. The Stock Options were fully vested as of the grant date. /s/ Megan N. Gates, Attorney-in-fact 2012-01-04